NEW YORK (GenomeWeb News) – Advocates for federal spending on biomedical research want to put a face on the pain inflicted by the long-term budget cuts and the recent sequestration that have struck the National Institutes of Health.

The 25 percent that has been eroded out of NIH appropriations over the past decade due to inflation, and the $1.6 billion that was hacked from its annual spending this year are "very abstract" numbers, Carrie Wolinetz, president of the group United for Medical Research, said in a conference call yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.